[1] S. H. Bae, W. Park, S. Han, et al. "Physiologically-based pharmacokinetic predictions of intestinal
BCRP-mediated drug interactions of rosuvastatin in Koreans". In: _The Korean Journal of Physiology &
Pharmacology_ 22.3 (2018), p. 321. DOI: 10.4196/kjpp.2018.22.3.321. <URL:
https://doi.org/10.4196/kjpp.2018.22.3.321>.

[2] S. Choi, S. Jeon, and S. Han. "Population pharmacokinetic analysis of metformin administered as
fixed-dose combination in Korean healthy adults". In: _Translational and Clinical Pharmacology_ 26.1
(2018), p. 25. DOI: 10.12793/tcp.2018.26.1.25. <URL: https://doi.org/10.12793/tcp.2018.26.1.25>.

[3] S. Han, G. H. Na, and D. Kim. "A 6-month mixed-effect pharmacokinetic model for post-transplant
intravenous anti-hepatitis B immunoglobulin prophylaxis". In: _Drug Design, Development and Therapy_ Volume
11 (7. 2017), pp. 2099-2107. DOI: 10.2147/dddt.s134711. <URL: https://doi.org/10.2147/dddt.s134711>.

[4] W. Huh, H. Oh, J. S. Han, et al. "Hydrochlorothiazide does not increase furosemide's effects in
end-stage renal disease". In: _Translational and Clinical Pharmacology_ 25.1 (2017), p. 28. DOI:
10.12793/tcp.2017.25.1.28. <URL: https://doi.org/10.12793/tcp.2017.25.1.28>.

[5] D. Jang, S. Han, and D. Yim. "Development of an automated appendix generation system (ARGUS) for
clinical study reports". In: _Translational and Clinical Pharmacology_ 25.1 (2017), p. 34. DOI:
10.12793/tcp.2017.25.1.34. <URL: https://doi.org/10.12793/tcp.2017.25.1.34>.

[6] G. Park, S. H. Bae, W. Park, et al. "Drug&ndash$\mathsemicolon$drug interaction of microdose and
regular-dose omeprazole with a CYP2C19 inhibitor and inducer". In: _Drug Design, Development and Therapy_
Volume11 (3. 2017), pp. 1043-1053. DOI: 10.2147/dddt.s131797. <URL: https://doi.org/10.2147/dddt.s131797>.

[7] W. Park, G. Park, S. Han, et al. "Human microdosing and mice xenograft data of AGM-130 applied to
estimate efficacious doses in patients". In: _Cancer Chemotherapy and Pharmacology_ 80.2 (6. 2017), pp.
363-369. DOI: 10.1007/s00280-017-3373-y. <URL: https://doi.org/10.1007/s00280-017-3373-y>.

[8] N. Rajasekaran, H. S. Jung, S. H. Bae, et al. "Effect of HPV E6/E7 siRNA with Chemotherapeutic Agents
on the Regulation of TP53/E2F Dynamic Behavior for Cell Fate Decisions". In: _Neoplasia_ 19.10 (10. 2017),
pp. 735-749. DOI: 10.1016/j.neo.2017.07.005. <URL: https://doi.org/10.1016/j.neo.2017.07.005>.

[9] D. Yim. "Five years of the CiPA project (2013\textendash2018): what did we learn?" In: _Translational
and Clinical Pharmacology_ 26.4 (2018), p. 145. DOI: 10.12793/tcp.2018.26.4.145. <URL:
https://doi.org/10.12793/tcp.2018.26.4.145>.

[10] D. Yim. "Tutorial for beginners: the concept of clearance explained using the example of a vacuum
cleaner". In: _Translational and Clinical Pharmacology_ 25.1 (2017), p. 1. DOI: 10.12793/tcp.2017.25.1.1.
<URL: https://doi.org/10.12793/tcp.2017.25.1.1>.
